Health care counsel with an insider’s perspective 

Amy Cotton Peterson helps entities in the health care industry navigate the labyrinth of laws and regulations governing their operations and evolving businesses. With deep knowledge of constantly evolving technologies, service models and clients’ business needs, she advises on:

• Health care transactions, representing buyers, sellers and investors in all aspects of the sale or purchase of health care entities.
• Regulatory compliance, advising on federal and state regulations governing licensure, privacy, Medicaid and Medicare reimbursement, clinical trials, provider self-referral and false claims.
• Provider defense, representing and defending providers before professional licensing boards and state and federal regulatory agencies.
• Business operations and development, counseling clients through internal and remedial investigations and obtaining regulatory approval for novel business initiatives.

As a former licensed physical therapist, Amy brings an inside-the-industry perspective to the legal and regulatory issues facing providers and related entities.

Bar Admissions

• Arizona

Education

• A.T. Still University (M.S.P.T., 1999)

• Harvard Law School Executive Education

• Pepperdine Caruso School of Law (J.D., 2005)
  • CALI Future Excellence Award, Entertainment Law

• Truman State University (B.S., cum laude, 1996)

• "Concerns Over Drug Compounding Bills on Capitol Hill"
• "Emerging Issues in Specialty Pharmacy"
• "Health Care Changes Under President Trump"
• "Hot Topics in Pharmacy Law"
• "How Can a Physical Therapist Avoid Common Mistakes When Responding to a P.T. Board Investigation?"
• "Implementation of an Effective Compliance Plan"
• "Industry/Business of Pharmacy"
• "Legal Issues in Specialty Pharmacy"
• "New and Improved? - A Discussion of New and Proposed State Regulations"
• "Specialty Pharmacy and the Law"
• "The Ethics of Personalized Medicine"
• "What's New in Pharmacy?"
• A Welcome Goodbye: Congress Repeals $2,010 Therapy Cap
• April is National Autism Awareness Month
• California Follows the Lead of Other States in Heightening the Scrutiny of Health Care Transactions
• California’s Pre-Closing Health Care Transaction Review Regulations Take Effect: Where Did We Land?
• Is Your Fitbit FDA-Legit?
• Kentucky Board of Pharmacy Continues to Research and Review Proposed Non-Resident Pharmacy Permit Regulations
• Kentucky Board of Pharmacy Regulation Committee Proposes New Requirement of Licensure for All Out-of-State Pharmacists
• New DOJ Policy for M&A Transactions Promotes Thorough Due Diligence and Voluntary Self-Disclosures
• Pharmacy Law Trends Q&A: Opioids, Specialty Drugs Among Top Issues for Retail Pharmacies
• Pharmacy Law: Technology Issues Faced by Pharmacies Across the Country
• Private Equity Groups and Hedge Funds – Be Aware of Proposed California Legislation Potentially Imposing Further Approval Requirements and Restrictions on Certain Health Care Transactions
• Safeway Prevails on Motion for Summary Judgment in Whistleblower Pharmacy Usual and Customary Pricing Case
• Senate Sets Sights on Drug Compounding: But Does it Solve the Problems?
• Telepharmacy, Telemedicine, AIC, and Other Alternative Sites of Care
• ​U.S. Supreme Court Rules that State Licensing Board Is Not Immune From Anti-Trust Claims

Seminar

• 2015 Pharmacy Law Symposium
• 2019 Pharmacy Law Symposium
• 2022 Pharmacy Law Symposium
• 2023 Pharmacy Law Symposium
• Emergent Technologies Panel Discussion
• Implementation of an Effective Compliance Plan
• NASP 2019 Annual Meeting & Expo 4th Annual Specialty Pharmacy Law Conference
• NASP 2020 Annual Meeting & Expo Virtual Experience and 5th Annual Specialty Pharmacy Law Conference
• State of the Law in Specialty Pharmacy
• State Pharmacy Licensure & Compliance
• WESTMARC Healthcare Innovation Summit